Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05658861 · ClinicalTrials.gov registry record · NA
Comparing the Gastric Transit of Commercial Milk and A2 Milk
A NA study, sponsored by Purdue University.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT05658861 is a NA study that has completed, run by Purdue University. The registered enrollment target is 10 participants.
The verdict
NCT05658861, a NA study, has completed, sponsored by Purdue University.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
Cow's milk contains two types of β-casein: A1 and A2. The μ-opioid peptide BCM-7 is released from A1 but not from A2. BCM-7 is associated with slower gastrointestinal transit and hence increased gastrointestinal transit times. Lactose maldigesters reported an increase in abdominal pain due to consumption of milk containing A1 beta-casein as compared to milk containing only A2 beta-casein. The hypothesis of this study is that the differential abdominal pain is due to the differential gastric transit. This is a double-blinded, randomized, controlled trial conducted to determine if the transit of A1 β-casein milk is modified in the stomach as compared to milk with only A2 β-casein.
Interventions
- OTHER Milk containing A1 and A2 beta-casein
- OTHER Milk containing only A2 beta-casein
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2021-06-21 |
| Est. Completion | 2022-12-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05658861
The ClinicalTrials.gov registry entry for NCT05658861 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Purdue University, which has 141 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Milk containing A1 and A2 beta-casein is the first listed.
NCT05658861 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05658861 about?
NCT05658861 is a clinical study titled "Comparing the Gastric Transit of Commercial Milk and A2 Milk". Cow's milk contains two types of β-casein: A1 and A2. The μ-opioid peptide BCM-7 is released from A1 but not from A2. BCM-7 is associated with slower gastrointestinal transit and hence increased gastrointestinal transit times. Lactose maldigesters reported an increase in abdominal pain due to consum...
What is the current status of trial NCT05658861?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2021-06-21. Estimated completion is 2022-12-01.
What interventions are being tested in trial NCT05658861?
The interventions under investigation include: Milk containing A1 and A2 beta-casein (OTHER), Milk containing only A2 beta-casein (OTHER).
Who is sponsoring clinical trial NCT05658861?
This trial is sponsored by Purdue University, which has 141 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.